Journal of Thyroid Disorders & Therapy

Journal of Thyroid Disorders & Therapy
Open Access

ISSN: 2167-7948

+44 1300 500008

Sergio Abanades

Department of Pharmacology, International College of Human Nutrition and Functional Medicine, París, 3r 1a Barcelona, Spain

Biography

Dr. Sergio Abanades is a distinguished medical professional specializing in Clinical Pharmacology and Toxicology. He earned his medical degree from the Complutense University of Madrid and completed his specialization in Clinical Pharmacology at the Municipal Institute of Medical Research (IMIM)–Hospital del Mar in Barcelona. He further obtained a Master's in Toxicology from the University of Seville and a Ph.D. in Pharmacology from the Autonomous University of Barcelona, graduating cum laude with a European Doctor Mention diploma. Dr. Abanades has an extensive background in both clinical practice and research. He has served as a clinical investigator and contributed to numerous peer-reviewed journals. His academic roles have included positions as an Honorary Professor of Pharmacology and Toxicology at Imperial College London and as an Associate Professor of Pharmacology at the Autonomous University of Barcelona. Notably, he was the Clinical Director at GlaxoSmithKline's Clinical Imaging Centre in London from 2007 to 2009. In 2009, Dr. Abanades founded the Institute of Integrative and Conscious Health (ISIC) in Barcelona, where he integrates conventional medicine with complementary practices, focusing on detoxification, micronutrition, and personal and spiritual transformation.

Publications

  • Research Article   
    Etiopathogenetic Mechanisms in Hashimoto?s Autoimmune Thyroid Disease
    Author(s): Isabel García* and Sergio Abanades

    Hashimoto’s disease (HD) is an autoimmune thyroid disease often leading to hypothyroidism. The current therapy for these patients consists in traditional Hormone Replacement Therapy (HRT) to compensate inadequate thyroid function. However, clinical management of this and other autoimmune disorders usually dismisses the etiologic component, even when the gold-standard pharmacological treatment is not effective and/or the patient remains asymptomatic. Here, we propose to dig into the etiopathogenic factors as an attempt to unravel patient’s negative response to therapy and to improve therapeutic and preventive approaches as standard medical practice as well as to complement HRT. These factors may include genetic susceptibility, intestinal permeability defects, other pathologies like celiac disease, gluten intolerance and biopsychosocialstress, gender, se.. View More»

    Abstract HTML PDF

Other relevant publications from this author
Top